Fielder Capital Group LLC

Position in ABBV — AbbVie Inc.

CIK 2010765 NASHVILLE, TN

Position in ABBV

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$637,152

+$95,820 QoQ

Shares Held

2,532

+1.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#2,951

of 4,153 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 18% Shared 0% None 82%

Healthcare · as of Jun 30, 2026

Fielder Capital Group LLC holds $3,492,667 across 6 Drug Manufacturers - General names. ABBV ranks #4 (18.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	6,488	$833,708
2	LLY	ELI LILLY & Co	694	$832,404
3	JNJ	Johnson & Johnson	2,638	$669,972
4	ABBV	AbbVie Inc. This page	2,532	$637,152
5	BMY	Bristol Myers Squibb Co	5,332	$307,229
6	AMGN	Amgen Inc	586	$212,202

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$637,152	2,532	+1.7%	Shares	Sole	2026-08-06
2026-03-31	$541,332	2,489	+0.6%	Shares	Sole	2026-05-12
2025-12-31	$565,512	2,475	-0.6%	Shares	Sole	2026-02-10
2025-09-30	$576,766	2,491	-1.0%	Shares	Sole	2025-11-06
2025-06-30	$467,019	2,516	+4.2%	Shares	Sole	2025-07-31
2025-03-31	$505,781	2,414	+1.3%	Shares	Sole	2025-05-07
2024-12-31	$423,281	2,382	+5.0%	Shares	Sole	2025-02-05
2024-09-30	$448,082	2,269	+0.6%	Shares	Sole	2024-11-12
2024-06-30	$386,777	2,255	+3.5%	Shares	Sole	2024-08-01
2024-03-31	$396,613	2,178	+0.6%	Shares	Sole	2024-04-25
2023-12-31	$335,665	2,166	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.